Author

Lorenza Rimassa

Current and emerging medical treatments for advanced biliary tract cancers
Current and emerging medical treatments for advanced biliary tract cancers

Lorenza Rimassa

FGFR2 fusion inhibitors: Updates on efficacy and therapy resistance
FGFR2 fusion inhibitors: Updates on efficacy and therapy resistance

Lorenza Rimassa

Therapy for intermediate HCC: Systemic therapy or loco-regional
Therapy for intermediate HCC: Systemic therapy or loco-regional

Lorenza Rimassa  et al.

EARLY SARS-COV-2-RELATED MORTALITY OF LIVER CANCER PATIENTS: CANCER STAGE MATTERS
EARLY SARS-COV-2-RELATED MORTALITY OF LIVER CANCER PATIENTS: CANCER STAGE MATTERS

Lorenza Rimassa  et al.

THE SYSTEMIC INFLAMMATORY RESPONSE IDENTIFIES PATIENTS WITH ADVERSE CLINICAL OUTCOME FROM IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA
THE SYSTEMIC INFLAMMATORY RESPONSE IDENTIFIES PATIENTS WITH ADVERSE CLINICAL OUTCOME FROM IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA

Lorenza Rimassa  et al.

Item 1 - 5 / 5
1